Document text
Principal Investigator: Faraz Choudhury
Organization: IMMUTO SCIENTIFIC, INC.
Fiscal Year: 2024
Award: $612,291
Funding agency: National Institute of General Medical Sciences
Abstract
Immuto Scientific Inc. is developing a robust, automated benchtop instrument to perform high-throughput
structural characterization of protein biotherapeutics in a fraction of time of traditional structural
characterization techniques such as x-ray crystallography and cryo-EM. Protein-based biotherapeutics (such
as antibodies, insulin, recombinant vaccines, etc.) are one of the most effective classes of modern medicines
for the treatment of a wide variety of diseases including cancers, autoimmunity/inflammation, genetic disorders,
and infectious diseases such as COVID-19. The biological function and physicochemical properties of
biotherapeutics are determined by their higher order structures (HOS)—the folding and three-dimensional
conformation that largely dictates function and stability. Therefore, it is imperative to analyze the three-
dimensional higher order structure of protein therapeutics at several stages of the drug development process
to ensure both safety and efficacy of the drug. Biopharmaceutical manufacturers are required to demonstrate
the consistency of the protein HOS conformation to the regulatory agencies. Moreover, identifying the binding
site of a therapeutic protein (such as a monoclonal antibody) to its corresponding antigen (known as epitope
mapping) is critical for the development of new antibody therapeutics, vaccines and diagnostics. Food and
Drug Administration (FDA) guidelines require specific binding site information between a drug and its target for
the regulatory filing. Current techniques for protein HOS characterization and epitope mapping are complex,
resource intensive and can take up to 6-12 months to perform. Based on feedback received from over 300
customer pharmaceutical customers, we have developed a technology called Plasma Induced Modification to
Biomolecules (PLIMB) that addresses the need of the industry for routine structural, mass spectrometry-based
protein HOS analysis. PLIMB generates sub microsecond bursts of hydroxyl (OH) radicals from water to label
proteins in solution. The OH radicals covalently label the solvent accessible regions of the protein and
subsequent mass spectrometric analysis reveals single amino acid level structural information. With PLIMB,
HOS analysis and epitope mapping can be performed in under 48 hours where current techniques such as x-
ray crystallography and Cryo-EM takes several months to perform. In Phase II, we will first incorporate the
hydroxyl radical detection system that was designed in Phase I into a fully automated, manufacturable PLIMB
instrument, and then validate the PLIMB system for commercial use. Ultimately, PLIMB will be a revolutionary
new tool for pharmaceutical researchers that will provide new capabilities to better engineer highly effective
protein biotherapeutics and accelerate the drug discovery timeline.
Terms: <3-D><3-D analysis><3-D structure><3-Dimensional><3-dimensional analysis><3-dimensional structure><3D><3D analysis><3D structure><Acceleration><Address><Adopted><Amino Acids><Amplifiers><Antibodies><Antigens><Autoimmune Diseases><Autoimmune Status><Autoimmunity><Binding Sites><Biological Agent><Biological Function><Biological Process><Biological Products><Biological Response Modifier Therapy><Biological Therapy><Biotech><Biotechnology><Blood Plasma><COVID-19><CV-19><Cancers><Cell Communication and Signaling><Cell Signaling><Clinical Treatment Moab><Collaborations><Combining Site><Communicable Diseases><Complex><Computer software><Consumption><Coronavirus Infectious Disease 2019><Coupling><Cryo-electron Microscopy><Cryoelectron Microscopy><Data><Data Analyses><Data Analysis><Development><Diagnostic><Disease><Disorder><Dose><Double-Blind Method><Double-Blind Study><Double-Blinded><Double-Masked Method><Double-Masked Study><Drug Industry><Drugs><Electron Cryomicroscopy><Engineering><Ensure><Epitope Mapping><Exposure to><Feedback><Fiber Optics><Food and Drug Administration><Genetic Diseases><Goals><Guidelines><Health><Higher Order Chromatin Folding><Higher Order Chromatin Structure><Higher Order Structure><Hour><Human><Humulin R><Hydrogen Oxide><Hydroxyl><Hydroxyl Radical><Industry><Industry Standard><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Inflammation><Insulin><Intracellular Communication and Signaling><Investigators><Knowledge><Label><Laser Electromagnetic><Laser Radiation><Lasers><Life><Malignant Neoplasms><Malignant Tumor><Manufacturer><Marketing><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Measurement><Measures><Medication><Medicine><Methionine><Methods><Modern Man><Modern Medicine><Modification><Molecular Configuration><Molecular Conformation><Molecular Stereochemistry><Monoclonal Antibodies><Novolin R><Outcome><Performance><Peroxides><Pharmaceutic Industry><Pharmaceutical Agent><Pharmaceutical Industry><Pharmaceutical Preparations><Pharmaceuticals><Pharmacologic Substance><Pharmacological Substance><Phase><Phase I Study><Plasma><Plasma Serum><Preparation><Process><Property><Protein Engineering><Protein Footprinting><Protein Region><Proteins><Quality Control><Reactive Site><Recombinant Vaccines><Regular Insulin><Reproducibility><Research Personnel><Research Resources><Researchers><Resolution><Resources><Reticuloendothelial System, Serum, Plasma><SBIR><Safety><Sampling><Signal Transduction><Signal Transduction Systems><Signaling><Single Crystal Diffraction><Small Business Innovation Research><Small Business Innovation Research Grant><Software><Solvents><Source><Speed><Structure><Surface><System><Techniques><Technology><Testing><Therapeutic antibodies><Three-dimensional analysis><Time><Tube><USFDA><United States Food and Drug Administration><Universities><Vaccines><Water><Wisconsin><X Ray Crystallographies><X-Ray Crystallography><X-Ray Diffraction Crystallography><X-Ray/Neutron Crystallography><Xray Crystallography><aminoacid><antibody and antigen binding><autoimmune condition><autoimmune disorder><autoimmunity disease><biological signal transduction><biological therapeutic><biological treatment><biologically based therapeutics><biologics><biopharmaceutical><biotherapeutic agent><biotherapeutics><biotherapy><commercial application><conformation><conformational><conformational state><conformationally><conformations><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><cryo-EM><cryoEM><cryogenic electron microscopy><data interpretation><design><designing><detection platform><detection system><developmental><drug development><drug discovery><drug efficacy><drug/agent><genetic condition><genetic disorder><genetic protein engineering><immunogen><improved><instrument><mAbs><malignancy><manufacture><methionine sulfoxide><monoclonal Abs><native protein drug><neoplasm/cancer><oxidation><performance tests><pharmaceutical><pharmaceutical protein><phase 1 study><photomultiplier><preparations><protein design><protein drug agent><protein structure><protein structures><protein-based drug><proteins structure><prototype><rapid growth><resolutions><response><therapeutic protein><three dimensional><three dimensional structure><timeline><tool><voltage>